vTv Therapeutics Announces Positive Study Results of Potential First-in-Class Oral Adjunctive Therapy for T1D

On February 10, vTv Therapeutics announced positive study results from the second part of the Phase 2 Simplici-T1 Study of TTP399.

Dexcom G7 Updates with CEO Kevin Sayer

Dexcom CEO Kevin Sayer discusses Dexcom’s international strategy, the next-generation Dexcom G7, and the response to the Dexcom Follow outage last Fall.

COVID-19 Diabetes Supply Chain Updates

Here, you'll find continuous updates on the status of the diabetes supply chain, with up to date information from all major insulin and device manufacturers as it relates to COVID-19.

COVID-19 Q+A with Endocrinologist Dr. Anne Peters

Dr. Anne Peters, a clinical diabetologist at the USC, recently took the time to answer questions about COVID-19 sourced from the Beyond Type 1 community.

Think You Have Coronavirus? Here’s What To Do

Do you think you've contracted coronavirus? Here are immediate steps to take to ensure you best treat yourself and limit the impact you have on those around you.

Sleep Away: Sleeping + Diabetes in College

Makaila talks about going away to school for the first time and how the transition specifically affected her Type 1 diabetes and sleep routine.

The Dawn Phenomenon

Nalani Haviland, MCMSc, PA-C explains the Dawn Phenomenon that some encounter in the morning, and shares tips for both those using MDI and pump therapy.

A Lifetime of Sleeping With Diabetes Tech

Lala shares her take on spending much of her life sleeping with diabetes technology and how she deals with it when it gets in the way of her rest.

Omnipod Closed Loop Technology to be Compatible with both Abbott and Dexcom CGMs

Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. 

FDA Issues Class I Recall of Certain Medtronic Insulin Pumps

The FDA announced Wednesday that it has issued a Class 1 recall of Medtronic MiniMed 600 Series insulin pumps, after reports of 2,175 injuries and 1 death.

JDRF CEO to Health Insurers: Cover New Technology

JDRF President & CEO Aaron Kowalski, Ph.D calls on insurers to cover FDA approved type 1 diabetes technology

Cracking the Code: CEO Eran Atlas Talks DreaMed’s Revolutionary Tech

Beyond Type 1 chats with Eran Atlas, founder and CEO of DreaMed, a company leveraging revolutionary technology to better diabetes care.

Invincible: The T1D App for Teaching Caregivers

Bob Weishar, founder of Invincible, saw the need to teach non-healthcare personnel at schools all about T1D and how to best support their students.

Omnipod Dash System Launches in First European Countries

On December 18, Insulet announced that the Omnipod DASH™ Insulin Management System is now officially available in the UK and the Netherlands. 

Everyone with Diabetes Should Have Access to CGM: Dr. Aaron Neinstein’s Take

Dr. Neinstein was one of four featured experts during Beyond Type 1’s #KnowledgeDrop Series, discussing the future of diabetes care, focusing specifically on technology, data, and emerging therapies.